Hanmi Pharmaceutical Investor
Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years.
Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories.
Headquarters:
Seoul,Seoul-t'ukpyolsi,South Korea,Asia
Employee Number:
5001-10000
Industry:
AI in HealthTech
Investor Type:
Private Equity Funds
Founded Date:
1973-01-01
Funding Status:
private
